The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine

Name: The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine
Published: 2021
License: Public Domain

Zhejiang Provincial Center for Disease Control and Prevention · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

immunogenicity measles safety

human papilloma virus infection type 16, human papilloma virus infection type 18, measles, rubella, mumps, immunogenicity, safety, recombinant human papillomavirus bivalent (types 16,18) vaccine (escherichia coli), measles mumps and rubella combined vaccine, live, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine

Related documents